Technical Analysis for GOVX - Geovax Labs Inc

Grade Last Price % Change Price Change
grade F 0.0295 -1.67% -0.0005
GOVX closed down 1.67 percent on Friday, August 23, 2019, on 77 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical GOVX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -1.67%
Volume Surge Other -1.67%
Narrow Range Bar Range Contraction -1.67%
Wide Bands Range Expansion -1.67%
Oversold Stochastic Weakness -1.67%
Narrow Range Bar Range Contraction -26.07%

Older signals for GOVX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs are focused on preventive vaccines against HIV, Zika virus, Hemorrhagic Fever viruses (Ebola, Sudan, Marburg, Lassa), and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. Our vaccine platform supports in vivo production of non-infectious VLPs in the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the ijmmune system to recognize, prevent, and control the target infection.
Medicine Biotechnology Medical Specialties Infectious Diseases Cancers Hiv Vaccines Malaria Bavarian Nordic Virus Ebola Viruses Chronic Hepatitis B Infections Geovax Hemorrhagic Fever Viruses Modified Vaccinia Ankara Vaccinia
Is GOVX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 1.23
52 Week Low 0.0075
Average Volume 105,336
200-Day Moving Average 0.1369
50-Day Moving Average 0.3299
20-Day Moving Average 0.0692
10-Day Moving Average 0.0409
Average True Range 0.0388
ADX 39.36
+DI 15.9551
-DI 35.8852
Chandelier Exit (Long, 3 ATRs ) 0.0936
Chandelier Exit (Short, 3 ATRs ) 0.1448
Upper Bollinger Band 0.1406
Lower Bollinger Band -0.0022
Percent B (%b) 0.22
BandWidth 206.358382
MACD Line -0.0794
MACD Signal Line -0.0919
MACD Histogram 0.0125
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0319
Resistance 3 (R3) 0.0318 0.0309 0.0315
Resistance 2 (R2) 0.0309 0.0303 0.0310 0.0314
Resistance 1 (R1) 0.0302 0.0299 0.0306 0.0303 0.0312
Pivot Point 0.0293 0.0293 0.0295 0.0294 0.0293
Support 1 (S1) 0.0286 0.0287 0.0290 0.0287 0.0278
Support 2 (S2) 0.0277 0.0283 0.0278 0.0276
Support 3 (S3) 0.0270 0.0277 0.0275
Support 4 (S4) 0.0271